Investor Relations

Investor Relations

Nov 4 8:30 AM EDT Nov 4, 2021 | 8:30 AM EDT
Regeneron Pharmaceuticals Q3 2021 Earnings Conference Call

Sep 27 9:20 AM EDT Sep 27, 2021 | 9:20 AM EDT
Cantor Fitzgerald Virtual Global Healthcare Conference

Sep 20 8:30 AM EDT Sep 20, 2021 | 8:30 AM EDT
Regeneron Oncology Investor Event, ESMO 2021

btn Events

We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in nine FDA-approved medicines and numerous product candidates in a range of diseases, including blindness-causing eye diseases, severe inflammatory conditions like asthma and atopic dermatitis, hematologic conditions, pain and infectious diseases such as Ebola and COVID-19.

Analyst Center


Analyst Center

Interactive and downloadable financial data for investors and analysts

btn Analyst Center

Contact us

Investor Relations


Media Relations

Email Alerts

IR Tools